BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9471796)

  • 1. [The use of sirdalud in painful muscle tonic syndromes].
    Damulin IV
    Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of sirdalud in the drug therapy of pain in the spine].
    Iakhno NN; Damulin IV; Chernenko OA; Ianakaeva TA; Kondrat'eva ON; Kur'ianova PT
    Ter Arkh; 1994; 66(10):10-2. PubMed ID: 7863433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of tizanidine.
    Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
    Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke].
    Gekht AB; Burd GS; Selikhova MV; Iaish F; Beliakov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):22-9. PubMed ID: 9819884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sirdalud in the practice of the pediatric neurologist].
    Shumilina AP; Guzeva VI; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):45-6. PubMed ID: 9424348
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified release tizanidine: a review.
    Hutchinson DR
    J Int Med Res; 1989; 17(6):565-73. PubMed ID: 2697626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of sirdalud MR in patients with multiple sclerosis].
    Batysheva TT; Popova NF; Petrov SV; Kamchatnov PR; Zaĭtsev KA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):57-60. PubMed ID: 21322181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke.
    Gelber DA; Good DC; Dromerick A; Sergay S; Richardson M
    Stroke; 2001 Aug; 32(8):1841-6. PubMed ID: 11486114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of sirdalud in cerebral palsy in children].
    Brin IL; Kurenkov AL; Gotlib VIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(10):30-3. PubMed ID: 10536809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spasticity: current and future management. Royal College of Physicians, November 13, 1997.
    Hosp Med; 1998 Jan; 59(1):61-9. PubMed ID: 9798568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tizanidine action on spasticity.
    Milanov I; Georgiev D
    Acta Neurol Scand; 1994 Apr; 89(4):274-9. PubMed ID: 8042446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.